Atossa Therapeutics
ATOS
#9776
Rank
S$55.65 M
Marketcap
S$6.46
Share price
-0.10%
Change (1 day)
573.66%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -S$39.57 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$32.67 Million, an increase over its 2023 earnings that were of -S$38.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$39.57 Million21.12%
2024 -S$32.67 Million-15.25%
2023 -S$38.55 Million11.62%
2022 -S$34.54 Million30.84%
2021 -S$26.4 Million15.58%
2020 -S$22.84 Million3.41%
2019 -S$22.09 Million51.16%
2018 -S$14.61 Million40.41%
2017 -S$10.41 Million27.54%
2016 -S$8.16 Million-47.49%
2015 -S$15.54 Million-17.25%
2014 -S$18.78 Million35.91%
2013 -S$13.82 Million112.3%
2012 -S$6.51 Million46.53%
2011 -S$4.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.49 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.64 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.70 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$53.39 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$0.14 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-S$10.05 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA